Browse by author
Lookup NU author(s): Professor David KavanaghORCiD,
Professor Tim Goodship
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Central to the pathogenesis of atypical hemolytic uremic syndrome (aHUS) is over-activation of the alternative pathway of complement. Following the initial discovery of mutations in the complement regulatory protein, factor H, mutations have been described in factor I, membrane cofactor protein and thrombomodulin, which also result in decreased complement regulation. Autoantibodies to factor H have also been reported to impair complement regulation in aHUS. More recently, gain of function mutations in the complement components C3 and Factor B have been seen. This review focuses on the genetic causes of aHUS, their functional consequences, and clinical effect.
Author(s): Kavanagh D, Goodship T
Publication type: Review
Publication status: Published
Journal: Pediatric Nephrology
Print publication date: 07/06/2010
ISSN (print): 0931-041X
ISSN (electronic): 1432-198X